LSPN: Counsel grapple with AI’s impact on training and critical thinking

Experts at LSPN Boston stress the need for cross-disciplinary teams and careful training as artificial intelligence software becomes mainstream, reports Marisa Woutersen.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Life sciences leaders recognised at LSPN Awards USA 2025

8 May 2025 Wilson Sonsini, Desmarais, and Wolf Greenfield were among the winners at the inaugural LSPN Awards USA 2025 in Boston, which celebrated excellence in life sciences IP across 20 categories.

Americas

LSPN: Trump's policy storm causing chaos and confusion

7 May 2025 In just 100 days, the Trump administration has issued a record-breaking 90 executive orders—triggering operational uncertainty, staffing upheaval, and growing delays at the US Patent and Trademark Office, hears Marisa Woutersen at LSPN in Boston.

Americas

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

6 May 2025 The ‘Wands factors’ are extending patent litigation—allowing functionally defined claims to survive longer than expected, hears Marisa Woutersen in Boston.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

LSPN: Counsel grapple with AI’s impact on training and critical thinking

More on this story

Editor's picks

Editor's picks

More features